Statements (90)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:acquired_by |
gptkb:Danaher_Corporation
|
| gptkbp:acquisition |
Acquired by Beckman Coulter, Inc. in 1997
Acquired by Danaher Corporation in 2011 |
| gptkbp:acquisition_year |
gptkb:2011
|
| gptkbp:awards |
Recognized for innovation in diagnostics
|
| gptkbp:certification |
ISO 13485 certified
|
| gptkbp:community_engagement |
Supports STEM education initiatives
Donates to health-related charities Promotes employee volunteerism. Involved in local health programs Participates in health fairs and screenings |
| gptkbp:community_involvement |
Engages in community health initiatives
|
| gptkbp:customer_base |
gptkb:Laboratories
Research institutions Hospitals |
| gptkbp:employees |
approximately 11,000
Approximately 11,000 |
| gptkbp:founded |
gptkb:1935
|
| gptkbp:founder |
gptkb:Arnold_O._Beckman
gptkb:Howard_Hughes_Beckman |
| gptkbp:global_presence |
Operates in over 130 countries
|
| gptkbp:headcount |
Approximately 11,000 employees globally
|
| gptkbp:headquarters |
gptkb:Brea,_California,_USA
gptkb:Brea,_California |
| gptkbp:history |
Founded as Beckman Instruments, Inc.
|
| https://www.w3.org/2000/01/rdf-schema#label |
Beckman Coulter
|
| gptkbp:industry |
gptkb:medical_devices
|
| gptkbp:innovation |
Pioneered several diagnostic technologies
|
| gptkbp:key_people |
gptkb:David_A._H._Hsu
gptkb:David_J._H._Hsu gptkb:Michael_J._Mc_Gowan gptkb:Robert_J._H._Hsu gptkb:John_J._Mc_Gowan gptkb:Thomas_J._H._Hsu gptkb:William_J._H._Hsu gptkb:Robert_A._Mc_Culloch gptkb:Kathy_A._H._Hsu Richard J. H. Hsu Danaher Corporation (Parent Company) Howard Hughes Beckman (Founder) Robert J. Mc Culloch (CEO) Various executives in R& D and marketing |
| gptkbp:location |
gptkb:United_States
|
| gptkbp:market |
global
|
| gptkbp:market_position |
Leader in clinical diagnostics
Strong presence in life sciences |
| gptkbp:notable_products |
Automated analyzers
Cell counters Flow cytometers Hemoglobin analyzers Immunoassay systems |
| gptkbp:operating_income |
$1.5 billion (2010)
|
| gptkbp:parent_company |
gptkb:Danaher_Corporation
|
| gptkbp:partnerships |
Collaborates with universities for research
Collaborates with various healthcare organizations Engages with regulatory bodies for compliance Partners with distributors worldwide Works with healthcare providers for product development |
| gptkbp:product_line |
Immunology
Microbiology Hematology Point-of-care testing Molecular diagnostics Clinical chemistry Quality control products Laboratory automation Software solutions for laboratories |
| gptkbp:products |
Reagents
Laboratory instruments reagents diagnostic instruments |
| gptkbp:research_and_development |
Invests heavily in R& D
|
| gptkbp:revenue |
$3 billion (2020)
$3.1 billion (2010) |
| gptkbp:services |
Life sciences
Clinical diagnostics laboratory services |
| gptkbp:specialization |
life sciences
clinical diagnostics In vitro diagnostics |
| gptkbp:subsidiaries |
gptkb:Beckman_Coulter_Life_Sciences
gptkb:Beckman_Coulter_Inc. gptkb:Beckman_Coulter_Diagnostics |
| gptkbp:subsidiary |
gptkb:Danaher_Corporation
|
| gptkbp:sustainability |
Focuses on sustainable practices
|
| gptkbp:type |
gptkb:public_company
|
| gptkbp:website |
www.beckmancoulter.com
|
| gptkbp:bfsParent |
gptkb:Danaher_Corporation
|
| gptkbp:bfsLayer |
4
|